Australia New Zealand Food Standards Code Standard 1.3.4 Identity and Purity (Cth)
STANDARD 1.3.4
IDENTITY AND PURITY
Purpose
This Standard ensures that food additives, processing aids, novel food substances, vitamins and minerals and nutritive substances added to food in accordance with this Code meet appropriate specifications for identity and purity. In general, these specifications are those used by the international community.
Table of Provisions
1 Application
2 Substances with specifications in primary sources
3 Substances with specifications in secondary sources
4 Additional and supplementary requirements
Schedule Specifications of identity and purity for substances added to food where there are no references in the monographs specified in Standard 1.3.4
Clauses
1 Application
This Standard applies only to the following substances which are added to food in accordance with this Code, or sold for use in food –
(a) food additives;
(b) processing aids;
(c) vitamins and minerals;
(d) novel food substances; and
(e) nutritive substances.
2 Substances with specifications in primary sources
A substance must comply with a relevant monograph published in one of the following –
(a) the Schedule to this Standard; or
(b) Combined Compendium of Food Additive Specifications, FAO JECFA Monograph 1 (2005) as superseded by specifications published in FAO JECFA Monographs 3 (2006) and FAO JECFA Monographs 4 (2007) and FAO JECFA Monographs 5 (2008) and FAO JECFA Monographs 7 (2009) and FAO JECFA Monographs 10 (2010) and FAO JECFA Monographs 11 (2011), Food and Agriculture Organisation of the United Nations. Rome; or
(c) United States Pharmacopeial Convention (2014) Food Chemicals Codex. 9th ed, United States Pharmacopeial Convention, Rockville, MD.; or
(d) Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down specifications for food additives.
3 Substances with specifications in secondary sources
If there is no monograph applying to a substance under clause 2, the substance must comply with a relevant monograph published in one of the following –
(a) the British Pharmacopoeia 2010, TSO, Norwich (2010); or
(b) the United States Pharmacopeia, 34th Revision and The National Formulary, 29th Edition (2010); or
(c) the Pharmaceutical Codex, 12th Edition, Council of the Pharmaceutical Society of Great Britain. The Pharmaceutical Press, London (1994); or
(d) Martindale; The Complete Drug Reference. The Pharmaceutical Press London (2009); or
(e) the European Pharmacopoeia 6th Edition, Council of Europe, Strasbourg (2007); or
(f) the International Pharmacopoeia 4th Edition, World Health Organization, Geneva (2006 and 2008 supplement); or
(g) the Merck Index, 14th Edition, (2006); or
(h) the Code of Federal Regulations; or
(i) the Specifications and Standards for Food Additives, 8th Edition (2007), Ministry of Health and Welfare (Japan); or
(j) the International Oenological Codex (2010 supplementary edition), Organisation Internationale de la Vigne et du Vin (OIV).
4 Additional and supplementary requirements
Where no monograph applies to a substance by virtue of clauses 2 or 3, or where a monograph contains no specifications for identity and purity of a substance relating to arsenic or heavy metals, the substance must not contain on a dry weight basis more than –
(a) 2 mg/kg of lead;
(b) 1 mg/kg of arsenic;
(c) 1 mg/kg of cadmium;
(d) 1 mg/kg of mercury.
SCHEDULE
This Schedule contains specifications of identity and purity for substances added to food where there are no references in the monographs specified in this Standard.
Specification for high chromium yeast
Physical Tests
Appearance: Fine, free-flowing powder
Colour: Light off-white or light tan
Odour: Slight yeast aroma
Particle size: Min. 90% through a #100 USS screen
Chemical Tests
Moisture: Maximum 6%
Chromium: 1.8 – 2.25 g/kg
Specification for high molybdenum yeast
Physical Tests
Appearance: Fine, free-flowing powder
Colour: Light off-white or light tan
Odour: Slight yeast aroma
Particle size: Min. 85% through a #100 USS screen
Chemical Tests
Moisture: Maximum 6%
Molybdenum: 1.8 – 2.25 g/kg
Specification for oxidised polyethylene
Oxidised polyethylene (CAS 68441-17-8)# is the polymer produced by the mild air oxidation of polyethylene.
Average molecular weight min 1200 (osmometric)
Viscosity at 125°C min 200cP
Oxygen content max 9.1%
Acid value: max 70 mgKOH/g
(ASTM D 1386)*
Drop point: min 95° C
(ASTM D 566)*
Density (20°C) 0.93 – 1.05 g/cm3
(ASTM D 1298, D 1505)*
Extractable constituents (See note 1):
in water max. 1.5%
in 10% ethanol max 2.3%
in 3% acetic acid max 1.8%
in n-pentane max 26.0%
# CAS is the Chemical Abstracts Service (CAS) Registry Number.
* ASTM refers to standard test methods prepared by the American Society for Testing and Materials.
Note 1: Extraction of oxidised Polyethylene
25.0 g of finely ground oxidised polyethylene powder (particle size 300-1000 mm) are extracted for 5 hours in the Soxhlet apparatus with 350 mL of solvent. The solvent is then distilled off and the distillation residue is dried in a vacuum oven at 80-90°C. After weighing the obtained residue, the components soluble in the solvent are calculated in % weight (based on the initial weight used).
Specification for bromo-chloro-dimethylhydantoin
Bromo-chloro-dimethylhydantoin (CAS Number: 126-06-7)
Formula: C5H6BrCIN2O2
Formula weight: 241.5
Chemical Properties
Appearance: Solid or free flowing granules
Colour: White
Odour: Faint halogenous odour
Melting Point: 163-164ºC
Specific gravity: 1.8-2
Solubility in water: 0.2 g/100 g at 25ºC
Stability: Stable when dry and uncontaminated
Chemical Tests
Manufacturing process: Solid dimethylhydantoin (DMH) is dissolved in water with bromine and chlorine. The reaction is 0.5 mole bromine and 1.5 mole chlorine for one mole DMH. During the reaction the pH is kept basic by the addition of caustic soda. The wet product is transferred to a drier where it is dried to a powder at low temperature. The powder may then be tableted or granulated.
Assay
Procedure: Various analytical methods exist for analysis, namely, GLC, HPLC, UV and NMR. HPLC offers the best sensitivity.
Specifications for nucleotides
Description / Physical Constraints
Uridine – 5′ monophosphate disodium salt (UMP)
1. Empirical chemical formula: C9 H11N2 O9PNa2
In addition the compound must be of the 5 species, ie the disodium monophosphate structure is attached to the fifth carbon in the central structure.
2. Molecular weight: 368.15
3. Structure/ Physical character: Occurs as a colourless or white crystal or as a white crystalline powder. It is odourless and has a characteristic taste.
4. Solubility: Freely soluble in water; very slightly soluble in alcohol.
Adenosine- 5′ monophosphate (AMP)
1. Empirical chemical formula: C10H14N5O7P
In addition the compound must be of the 5 species, ie the monophosphate structure is attached to the fifth carbon in the central structure.
2. Molecular weight: 347.22
3. Structure/ Physical character: Occurs as a colourless or white crystal or as a white crystalline powder. It is odourless and has a characteristic acidic taste.
4. Solubility: Very slightly soluble in water; practically insoluble in alcohol.
Cytidine – 5′ monophosphate (CMP)
1. Empirical chemical formula: C9H14N3O8P
In addition the compound must be of the 5 species, ie the monophosphate structure is attached to the fifth carbon in the central structure.
2. Molecular weight: 323.20
3. Structure/Physical character: Occurs as a colourless or white crystal or as a white crystalline powder. It is odourless and has a characteristic slightly acidic taste.
4. Solubility: Very slightly soluble in water; practically insoluble in alcohol.
Testing Requirements for Nucleotides
1. Physical inspection: white crystals or crystalline powder
2. Identification:
(a) Ultraviolet absorbance: a 1 in 12,500 solution of the powder in 0.01N hydrochloric acid exhibits an absorbance maximum at:
| Absorbance | Nucleotide |
| 250+- 2nm | Inosine – 5′ monophosphate disodium salt |
| 260+- 2nm | Uridine – 5′ monophosphate disodium salt |
| 257+- 2nm | Adenosine – 5′ monophosphate |
| 280+- 2nm | Cytidine – 5′ monophosphate (CMP) |
| 256+- 2nm | Guanosine – 5′ monophosphate disodium salt (GMP) |
(b) IMP, UMP and GMP must test positive for sodium phosphate
(c) IMP,UMP,AMP, CMP and GMP must test positive for organic phosphate
3. Assay (HPLC):
Optimum - not less than 96% (corrected for moisture content).
4. IMP and GMP have a pH of a 1 in 20 solution: between 7.0 and 8.5
5. Clarity and colour of solution:
500 mg/10 mL H2O for IMP: is colourless and shows only a trace of turbidity
100 mg/10 mL H2O for GMP: is colourless and shows only a trace of turbidity
6. Moisture
| Nucleotide | Moisture |
| Inosine – 5′ monophosphate disodium salt | Not more than 28.5%: Karl Fischer |
| Uridine – 5′ monophosphate disodium salt | Not more than 26.0%: Karl Fischer |
| Guanosine – 5′ monophosphate disodium salt (GMP) | Loss in drying - not more than 25% (4 hrs @ 120ºC) |
| Cytidine – 5′ monophosphate (CMP) | Not more than 6.0%: Loss in drying (4 hrs @ 120ºC) |
| Adenosine – 5′ monophosphate | Not more than 6.0%: Loss in drying (4 hrs @ 120ºC |
7. Impurities – all nucleotides
| Impurity | Nucleotide |
| Amino acids: negative | IMP, GMP |
| Ammonium salts: negative | IMP, GMP |
| Arsenic: not more than 2 ppm | IMP, UMP, AMP, CMP, GMP |
| Heavy metals: not more than 10 ppm | IMP, UMP, AMP, CMP, GMP |
8. Related foreign substances:
For IMP: only 5′ - inosinic acid is detected by thin layer chromatography
For GMP: only 5′ - guanylic acid is detected by thin layer chromatography
9. Bacteriological profile
(a) SPC: not more than 1000/g, test per current FDA/BAM procedures
(b) Coliforms: Negative by test; test per current FDA/BAM procedures
(c) Yeast and mould: not more than 300/g, test per current FDA/BAM procedures
(d) Salmonella: negative, test per current FDA/BAM procedures.
Specification for carboxymethyl cellulose ion exchange resin
(a) This specification relates to regenerated cellulose, cross-linked and alkylated with epichlorohydrin and propylene oxide, then derivatised with carboxymethyl groups whereby the amount of epichlorohydrin plus propylene oxide is no more than 70% by weight of the starting quantity of cellulose.
(b) The resins are limited to use in aqueous process streams for the isolation and purification of protein concentrates and isolates. The pH range for the resins shall be no less than 2 and no more than 10, and the temperatures of water and food passing through the resin bed must be no more than 40°C.
(c) When subjected to the extraction regime listed in the 21 CFR § 173.25(c)(4), but using dilute hydrochloric acid at pH2 in place of 5% acetic acid, the ion exchange resins shall result in no more than 25 ppm of organic extractives.
Specification for quaternary amine cellulose ion exchange resin
(a) This specification relates to regenerated cellulose, cross-linked and alkylated with epichlorohydrin and propylene oxide, then derivatised with quaternary amine groups whereby the amount of epichlorohydrin plus propylene oxide is no more than 250% by weight of the starting quantity of cellulose.
(b) The resins are limited to use in aqueous process streams for the isolation and purification of protein concentrates and isolates. The pH range for the resins shall be no less than 2 and no more than 10, and the temperatures of water and food passing through the resin bed must be no more than 50°C.
(c) When subjected to the extraction regime listed in the 21 CFR § 173.25(c)(4), but using dilute hydrochloric acid at pH2 in place of 5% acetic acid, the ion exchange resins shall result in no more than 25 ppm of organic extractives.
Specification for diethyl aminoethyl cellulose ion exchange resin
(a)This specification relates to:
(i) Regenerated cellulose, cross-linked and alkylated with epichlorohydrin and propylene oxide, then derivatised with tertiary amine groups whereby the amount of epichlorohydrin plus propylene oxide is no more than 70% by weight of the starting quantity of cellulose; and
(ii) Regenerated cellulose, cross-linked and alkylated with epichlorohydrin then derivatised with tertiary amine groups whereby the amount of epichlorohydrin is no more than 10% by weight of the starting quantity of cellulose.
(b) The resins are limited to use in aqueous process streams for the isolation and purification of protein concentrates and isolates. The pH range for the resins shall be no less than 2 and no more than 10, and the temperatures of water and food passing through the resin bed must be no more than 50°C.
(c) When subjected to the extraction regime listed in the 21 CFR § 173.25(c)(4), but using dilute hydrochloric acid at pH2 in place of 5% acetic acid, the ion exchange resins shall result in no more than 25 ppm of organic extractives.
Specification for dried marine micro-algae (Schizochytrium sp.) rich in docosahexaenoic acid (DHA)
| Full chemical name for DHA | 4,7,10,13,16,19-docosahexaenoic acid (22:6n-3 DHA) |
| Solids (%) | min. 95.0 |
| DHA (%) | min. 15.0 |
| Lead (mg/kg) | max. 0.5 |
| Arsenic (mg/kg) | max. 0.5 |
Specification for oil derived from marine micro-algae (Schizochytrium sp.) rich in docosahexaenoic acid (DHA)
| Full chemical name for DHA | 4,7,10,13,16,19-docosahexaenoic acid (22:6n-3 DHA) |
| DHA (%) | min. 32 |
| Trans fatty acids (%) | max. 2.0 |
| Lead (mg/kg) | max. 0.1 |
| Arsenic (mg/kg) | max. 0.1 |
| Mercury (mg/kg) | max. 0.1 |
| Hexane (mg/kg) | max. 0.3 |
Specification for oil derived from the algae Crypthecodinium cohnii rich in docosahexaenoic acid (DHA)
| Full chemical name for DHA | 4,7,10,13,16,19-docosahexaenoic acid (22:6n-3) |
| DHA (%) | min. 35 |
| Trans fatty acids (%) | max. 2.0 |
| Lead (mg/kg) | max. 0.1 |
| Arsenic (mg/kg) | max. 0.1 |
| Mercury (mg/kg) | max. 0.1 |
| Hexane (mg/kg) | max. 0.3 |
Specification for oil derived from the fungus Mortierella alpina rich in arachidonic acid (ARA)
| Full chemical name for ARA | 5,8,11,14-eicosatetraenoic acid (20:4n-6 ARA) |
| ARA (%) | min. 35 |
| Trans fatty acids (%) | max. 2.0 |
| Lead (mg/kg) | max. 0.1 |
| Arsenic (mg/kg) | max. 0.1 |
| Mercury (mg/kg) | max. 0.1 |
| Hexane (mg/kg) | max. 0.3 |
Specification for resistant maltodextrins
| Chemical structure | Glucopyranose linked by α(1-4), α(1-6), α/β(1-2), and α/β(1-3) glucosidic bonds; and contains levoglucosan. | |
| Dextrose equivalent | 8-12 | |
| Appearance | Free-flowing fine powder | |
| Colour | White | |
| Taste/odour | Slightly sweet/odourless | |
| Solution | Clear | |
| pH (in 10% solution) | 4-6 | |
| Moisture (%) | max. 5 | |
| Ash (%) | max. 0.2 | |
| Arsenic (ppm) | max. 1 | |
| Heavy metals (ppm) | max. 5 | |
| Microbiological | Standard plate count (cfu/g) | max. 300 |
| Yeast and mould (cfu/g) | max. 100 | |
| Salmonella | Negative to test | |
| Coliforms | Negative to test | |
Specification for oil derived from marine micro-algae (Ulkenia sp.) rich in docosahexaenoic acid (DHA)
| Full chemical name for DHA | 4,7,10,13,16,19-docosahexaenoic acid (22:6n-3 DHA) |
| DHA (%) | min. 32 |
| Trans fatty acids (%) | max. 2.0 |
| Lead (mg/kg) | max. 0.2 |
| Arsenic (mg/kg) | max. 0.2 |
| Mercury (mg/kg) | max. 0.2 |
| Hexane (mg/kg) | max. 10 |
Specification for ice structuring protein type III HPLC 12 preparation
Ice structuring protein type III HPLC 12 preparation is a protein excreted from the fermentation of a genetically modified yeast (Saccharomyces cerevisiae) to which a synthetic gene encoding for the protein has been inserted into the yeast’s genome.
| Assay | Not less than 5 g/L active ice structuring protein type III HPLC 12 |
| pH | 3.0+/-0.5 |
| Ash | Not more than 2% |
| Appearance | Light brown aqueous preparation |
| Heavy metals | Not more than 2 mg/L |
| Microbial limits | |
| Total microbial count | <3000 per g |
| Coliforms | <10 per g |
| Yeast and mould count | <100 per g |
| Listeria sp. | Absent in 25 g |
| Salmonella sp. | Absent in 25 g |
| Bacillus cereus | <100 per g |
Specification for isomaltulose
| Chemical name | 6-O-α-D-glucopyranosyl-D-fructofuranose |
| Description | White or colourless, crystalline, sweet substance, faint isomaltulose specific odour |
| Isomaltulose (%) | Not less than 98% on a dry weight basis |
| Water Other saccharides Ash Lead | Max. 6% Max. 2% on a dry weight basis Max. 0.01% on a dry weight basis Max. 0.1 ppm on a dry weight basis |
Specification for agarose ion exchange resin
(a) This specification relates to agarose, cross-linked and alkylated with epichlorohydrin and propylene oxide, then derivatised with tertiary amine groups whereby the amount of epichlorohydrin plus propylene oxide does not exceed 250% by weight of the starting quantity of agarose.
(b) The resins are limited to use in aqueous process streams for the removal of proteins and polyphenols from beer. The pH range for the resins shall be no less than 2 and no more than 5, and the temperatures of water and food passing through the resin bed shall not exceed 2˚C. pH and temperature restrictions do not apply to cleaning processes.
(c) When subjected to the extraction regime listed in the 21 CFR § 173.25(c)(4), but using dilute hydrochloric acid at pH 2 in place of 5% acetic acid, the ion exchange resins shall result in no more than 25 ppm of organic extractives.
Specification for bentonite
Bentonite must comply with a monograph specification in clause 2 or clause 3 of this Standard, except that the pH determination for a bentonite dispersion must be no less than 4.5 and no more than 10.5.
Specification for phytosterols, phytostanols and their esters
(1) Subject to subclauses (2) and (3), phytosterols, phytostanols and their esters must comply with a monograph specification in clause 2 or 3 of this Standard.
(2) However, for a mixture which contains no less than 950 g/kg of phytosterol and phytostanols, the concentration of hexane, isopropanol, ethanol, methanol or methyl ethyl ketone either singly or in combination must be no more than 2 g/kg.
(3) The total plant sterol equivalents content must contain no less than 95% des-methyl sterols.
Specification for tall oil phytosterol esters
| Tall oil phytosterol esters are phytosterols derived from Tall Oil Pitch esterified with long-chain fatty acids derived from edible vegetable oils Phytosterol Content | |
| Phytosterol esters + free phytosterols | No less than 97% |
| Free Phytosterols after saponification | No less than 59% |
| Free phytosterols | No more than 6% |
| Steradienes | No more than 0.3% |
| Sterol profile based on input sterols | |
| Campesterol | No less than 4.0% and no more than 25.0% |
| Campestanol | No more than14.0% |
| B-sitosterol | No less than 36.0% and no more than 79.0% |
| B-sitostanol | No less than 6.0% and no more than 34% |
| Fatty acid methylester | No more than 0.5% |
| Moisture | No more than 0.1% |
| Solvents | No more than 50 mg/kg |
| Residue on ignition | No more than 0.1% |
| Heavy Metals | |
| Iron | No more than 1.0 mg/kg |
| Copper | No more than 0.5 mg/kg |
| Arsenic | No more than 3 mg/kg |
| Lead | No more than 0.1 mg/kg |
| Microbiological | |
| Total aerobic count | No more than 10,000 cfu/g |
| Combined moulds and yeasts | No more than 100 cfu/g |
| Coliforms | Negative |
| E. coli | Negative |
| Salmonella | Negative |
Specifications for Advantame
1. Purity
| Specification Parameter | Specification Value | Analytical Methodology |
| Assay | Not less than 97.0% and not more than 102.0% on anhydrous basis | High pressure liquid chromatography (HPLC) |
| Specific rotation [α] 20 D | Between -45° and -38° | Japanese Pharmacopeia |
| Advantame-acid | Not more than 1.0% | HPLC |
| Total other related substances | Not more than 1.5% | HPLC |
| Water | Not more than 5.0% | Karl Fischer coulometric titration |
| Residue on ignition | No more than 0.2% | Japanese Pharmacopeia |
2. Residual Solvents
| Specification Parameter | Specification Value | Analytical Methodology |
| Methyl Acetate | No more than 500 mg/kg | Gas chromatography |
| Isopropyl Acetate | No more than 2000 mg/kg | Gas chromatography |
| Methanol | No more than 500 mg/kg | Gas chromatography |
| 2-Propanol | No more than 500 mg/kg | Gas chromatography |
Specification for dimethyl ether
| Characteristic | Specification |
| Purity | Minimum of 99.8% |
| Methanol | Not greater than 200 mg/kg |
Specification for dibromo-dimethylhydantoin
| Dibromo-dimethylhydantoin (CAS Number 77-48-5) | |
| Formula | C5H6Br2N2O2 |
| Purity | |
| Dibromo-dimethylhydantoin | No less than 97% |
| Sodium bromide | No more than 2% |
| Water | No more than 1% |
Specification for selenium-enriched yeast
Selenium-enriched yeasts are produced by culture in the presence of sodium selenite as a source of selenium. These yeasts contain selenium according to the following criteria –
| Total selenium content | No more than 2.5 mg/kg of the dried form as marketed |
| Levels of organic selenium species (% total extracted selenium): | |
| Selenomethionine | No less than 60% and no more than 85% |
| Other organic selenium compounds (including selenocysteine) | No more than 10% |
| Levels of inorganic selenium (% total extracted selenium) | No more than 1% |
Specification for Listeria phage P100
| Biological classification | |
| Order | Caudovirales |
| Family | Myoviridae |
| Subfamily | Spounaviridae |
| Genus | Twort-like |
| Species | Listeria phage P100 |
| GenBank Accession Number | DQ004855 |
Amendment History
The Amendment History provides information about each amendment to the Standard. The information includes commencement or cessation information for relevant amendments.
These amendments are made under section 92 of the Food Standards Australia New Zealand Act 1991 unless otherwise indicated. Amendments do not have a specific date for cessation unless indicated as such.
About this compilation
This is a compilation of Standard 1.3.4 as in force on 30 October 2014 (up to Amendment No. 150). It includes any commenced amendment affecting the compilation to that date.
Prepared by Food Standards Australia New Zealand on 30 October 2014.
Uncommenced amendments or provisions ceasing to have effect
To assist stakeholders, the effect of any uncommenced amendments or provisions which will cease to have effect, may be reflected in the Standard as shaded boxed text with the relevant commencement or cessation date. These amendments will be reflected in a compilation registered on the Federal Register of Legislative Instruments including or omitting those amendments and provided in the Amendment History once the date is passed.
The following abbreviations may be used in the table below:
ad = added or inserted am = amended
exp = expired or ceased to have effect rep = repealed
rs = repealed and substituted
Standard 1.3.4 was published in the Commonwealth of Australia Gazette No. P 30 on 20 December 2000 as part of Amendment No. 53 (F2008B00617 – 30 September 2008) and has been amended as follows:
| Clause affected | A’ment No. | FRLI registration Gazette | Commencement (Cessation) | How affected | Description of amendment |
| Purpose | 124 | F2011L01450 8 July 2011 FSC 66 11 July 2011 | 11 July 2011 | rs | Purpose. |
| 1 | 124 | F2011L01450 8 July 2011 FSC 66 11 July 2011 | 11 July 2011 | rs | Clause. |
| 2 | 60 | F2008B00813 23 Dec 2008 FSC 8 22 May 2003 | 22 May 2003 | am | Update reference in paragraph (a). |
| 2 | 69 | F2008B00816 24 Dec 2008 FSC 11 17 Dec 2003 | 17 Dec 2003 | am | Update reference in paragraph (b). |
| 2 | 78 | F2005L01246 26 May 2005 FSC 20 26 May 2005 | 26 May 2005 | am | Update reference in paragraphs (a) and (b). |
| 2 | 101 | F2008L03058 14 Aug 2008 FSC 43 14 Aug 2008 | 14 Aug 2008 | am | Update reference in paragraph (a). |
| 2 | 103 | F2008L03741 9 Oct 2008 FSC 45 9 Oct 2008 | 9 Oct 2008 | am | Update reference in paragraph (b). |
| 2 | 111 | F2009L03145 13 Aug 2009 FSC 53 13 Aug 2009 | 13 Aug 2009 | rs | Clause. |
| 2 | 124 | F2011L01450 8 July 2011 FSC 66 11 July 2011 | 11 July 2011 | rs | Clause |
| 2 | 135 | F2012L02014 10 Oct 2012 FSC 77 11 Oct 2012 | 11 Oct 2012 | am | Update references in paragraphs (b) and (c). |
| 2 | 150 | F2014L01427 28 Oct 2014 FSC92 30 Oct 2014 | 30 Oct 2014 | rs | Update reference in paragraph (c) and insert new paragraph (d). |
| 3 | 73 | F2008B00820 24 Dec 2008 FSC 15 5 Aug 2004 | 5 Aug 2004 | am | Update reference in paragraph (g). |
| 3 | 78 | F2005L01246 26 May 2005 FSC 20 26 May 2005 | 26 May 2005 | am | Update reference in paragraph (i). |
| 3 | 98 | F2008L01488 15 May 2008 FSC 40 15 May 2008 | 15 May 2008 | am | Update references in paragraphs (j) and (k). |
| 3 | 103 | F2008L03741 9 Oct 2008 FSC 45 9 Oct 2008 | 9 Oct 2008 | rs | Clause. |
| 3 | 111 | F2009L03145 13 Aug 2009 FSC 53 13 Aug 2009 | 13 Aug 2009 | rs | Clause. |
| 3 | 124 | F2011L01450 8 July 2011 FSC 66 11 July 2011 | 11 July 2011 | rs | Clause. |
| 3 | 150 | F2014L01427 28 Oct 2014 FSC92 30 Oct 2014 | 30 Oct 2014 | am | Update reference in paragraph (i). |
| 4 | 124 | F2011L01450 8 July 2011 FSC 66 11 July 2011 | 11 July 2011 | rs | Paragraph (c) and replace with paragraphs (c) and (d). |
| Schedule | 54 | F2008B00790 9 Dec 2008 P 17 14 June 2001 | 14 June 2001 | ad | Specifications for bromo-chloro-dimethylhydantoin and phytosterol esters derived from vegetable oils. |
| Schedule | 55 | F2008B00791 9 Dec 2008 P 23 30 Aug 2001 | 30 Aug 2001 | ad | Specification for neotame. |
| Schedule | 58 | F2008B00796 10 Dec 2008 P 28 20 Dec 2001 | 20 Dec 2001 | ad | Specifications for carboxymethyl, quaternary amine and diethyl aminoethyl cellulose-based ion exchange resins. |
| Schedule | 60 | F2008B00798 19 Dec 2008 FSC 2 20 June 2002 | 20 June 2002 | ad | Specifications for arachidonic acid-rich oils derived from Mortierella alpina, docosahexaenoic acid-rich dried marine micro-algae, docosahexaenoic acid-rich oil derived from dried marine micro-algae and docosahexaenoic acid-rich oil derived from Crypthecodinium cohnii, and tall oil phytosterols. |
| Schedule | 67 | F2008B00814 24 Dec 2008 FSC 9 31 July 2003 | 31 July 2003 | am | Correct a typographical error in specification for tall oil phytosterols derived from tall oils. |
| Schedule | 74 | F2008B00821 24 Dec 2008 FSC 16 14 Oct 2004 | 14 Oct 2004 | ad | Specification for resistant maltodextrins. |
| Schedule | 78 | F2005L01246 26 May 2005 FSC 20 26 May 2005 | 26 May 2005 | am | Correct a typographical error in paragraph (c) in the specification for quaternary amine cellulose ion exchange resin. |
| Schedule | 78 | F2005L01246 26 May 2005 FSC 20 26 May 2005 | 26 May 2005 | ad | Specification for docosahexaenoic acid-rich oil derived from marine micro-algae (Ulkenia sp). |
| Schedule | 83 | F2005L03673 24 Nov 2005 FSC 25 24 Nov 2005 | 24 Nov 2005 | ad | Specification for ice structuring protein type III HPLC 12. |
| Schedule | 88 | F2006L03270 5 Oct 2006 FSC 30 5 Oct 2006 | 5 Oct 2006 | am | References for nucleotides. |
| Schedule | 89 | F2006L03647 9 Nov 2006 FSC 31 9 Nov 2006 | 9 Nov 2006 | am | Specifications for tall oil phytosterols derived from tall oils. |
| Schedule | 92 | F2007L02406 2 Aug 2007 FSC 34 2 Aug 2007 | 2 Aug 2007 | ad | Specification for isomaltulose. |
| Schedule | 96 | F2008L00523 21 Feb 2008 FSC 38 21 Feb 2008 | 21 Feb 2008 | ad | Specification for agarose ion exchange resin. |
| Schedule | 103 | F2008L03741 9 Oct 2008 FSC 45 9 Oct 2008 | 9 Oct 2008 | am | ‘does not exceed’ or ‘shall not exceed’ and remove the border in the text for the specification for oxidised polyethylene. |
| Schedule | 103 | F2008L03741 9 Oct 2008 FSC 45 9 Oct 2008 | 9 Oct 2008 | rep | Specification for neotame. |
| Schedule | 111 | F2009L03145 13 Aug 2009 FSC 53 13 Aug 2009 | 13 Aug 2009 | ad | Specification for bentonite. |
| Schedule | 115 | F2010L00803 8 April 2010 FSC 57 8 April 2010 | 8 April 2010 | rep, ad | Omit specifications for phytosterol esters derived from vegetable oils and tall oil phytosterols derived from tall oils and insert specifications for phytosterols, phytostanols and their esters and tall oil phytosterol esters. |
| Schedule | 124 | F2011L01450 8 July 2011 FSC 66 11 July 2011 | 11 July 2011 | am | References in specifications for carboxymethyl cellulose, quaternary amine cellulose, diethyl aminoethyl cellulose and agarose ion exchange resins. |
| Schedule | 124 | F2011L01450 8 July 2011 FSC 66 11 July 2011 | 11 July 2011 | rs | Specifications for docosahexaenoic acid (DHA) –rich dried marine micro-algae (Schizochytrium sp.), docosahexaenoic acid (DHA) –rich oil derived from marine micro-algae (Schizochytrium sp.), docosahexaenoic acid (DHA) – rich oil derived from the algae Crypthecodinium cohnii, oil derived from the fungus Mortierella alpina rich in arachidonic acid (ARA) and docosahexaenoic acid (DHA) -rich oil derived from marine micro-algae (Ulkenia sp.). |
| Schedule | 125 | F2011L01829 7 Sept 2011 FSC 67 8 Sept 2011 | 8 Sept 2011 | ad | Specification for advantame. |
| Schedule | 130 | F2012L00929 26 April 2012 FSC 72 26 April 2012 | 26 April 2012 | ad | Specification for dimethyl ether. |
| Schedule | 131 | F2012L01060 22 May 2012 FSC 73 24 May 2012 | 24 May 2012 | ad | Specification for dibromo-dimethylhydantoin. |
| Schedule | 132 139 | F2012L01341 26 June 2012 FSC 74 28 June 2012 as am by F2013L00250 21 Feb 2013 FSC81 21 Feb 2013 | 21 Feb 2013 | ad | Specification for selenium-enriched yeast to take effect on 28 June 2014. Commencement date brought forward to 21 Feb 2013. |
| Schedule | 135 | F2012L02011 10 Oct 2012 FSC 77 11 Oct 2012 | 11 Oct 2012 | ad | Specification for Listeria phage P100. |
| Schedule | 135 | F2012L02014 10 Oct 2012 FSC 77 11 Oct 2012 | 11 Oct 2012 | am | Specification for nucleotides. |
| Schedule | 150 | F2014L01427 28 Oct 2014 FSC92 30 Oct 2014 | 30 Oct 2014 | am | Typographical error in heading for specification for selenium-enriched yeast. |
0
0
0